The biological effects of estrogen in mammalian target tissues are important for multiple organ systems including the male and female reproductive tract and the neuroendocrine, skeletal, and cardiovascular systems. Numerous physiological effects of estradiol are modulated by the estrogen receptor (ER), a Class I member of the nuclear receptor superfamily. However, more recent studies have also implicated nongenomic effects of estrogen, which may involve a membrane-binding site. The two forms of the ER are the classical estrogen receptor-alpha (ER␣) and the more recently discovered estrogen receptor-beta (ER␤). Genetargeting techniques were used to generate mice lacking either functional ER␣ (␣ERKO), ER␤ (␤ERKO), or both ERs (␣␤ERKO) to provide a model for evaluating estrogen receptor action. These knockout models provide a unique tool to study the effects of estrogen in the context of the whole animal and to discern the role of each ER in various tissues. The reproductive phenotypes as well as some of the nonreproductive phenotypes of the different ERKO models are summarized.
T wo estrogen receptors (ERs 1 ), alpha and beta, have been identified. Both ER␣ and ER␤ produce a protein product from a separate gene located on different chromosomes, and as Class I members of the nuclear hormone receptor superfamily, are composed of the following six functional domains, labeled A-F: (1) the N-terminal A/B domain; (2) the C domain containing the DNA-binding domain (DBD 1 ); (3) the D domain possessing signals for nuclear localization; (4) the E domain, or the ligand binding domain (LBD 1 ); (5) the C-terminal F domain, which is unique to the ERs among the nuclear receptors and not well conserved; and (6) the N-terminal domain of the ER, which contains a ligand-independent activation function (AF 1 )-1 (Nilsson et al. 2001 ) that appears to be more important in ER␣ than ER␤. The DBD contains two zinc finger structures that play an important role in binding the receptors to specific DNA sequences known as estrogen response elements (EREs 1 ) within the regulatory sequences of target genes. The DBD for ER␣ and ER␤ share a high degree of homology (97%) and are therefore likely to bind to the same EREs . The E domain mediates ligand binding and receptor dimerization, and establishes ligand specificity and transactivation of target gene expression via the AF-2 domain (Nilsson et al. 2001) . The AF-2 domain is critical to ligand-dependent transactivational activity as well as recruitment of coregualator proteins. ER␣ and ER␤ share a moderate degree of homology (60%) in LBD, show similar binding affinities for estradiol, and exhibit comparable binding affinities for a number of natural and synthetic ligands (Couse and Korach 1999a; Nilsson et al. 2001; Swope and Korach 2003) .
The classical ligand-dependent mechanism by which ER activates transcription of target genes requires that upon binding to ligand, the LBD undergoes a conformational change that allows interaction with coactivators (Bocchinfuso et al. 2000; Moggs and Orphanides 2001; Swope and Korach 2003) . The ligand-bound ER undergoes dimerization, binds to ERE sequence in target genes, and induces transcription. In addition to the classical mechanism, ER action can involve ligand-independent activation, in which ER activation results in the absence of estrogen. Ligandindependent activation of ER can be modulated by a number of signaling pathways including growth factors, protein kinase A, and protein kinase C. Estrogen target genes may also be regulated by ER in the absence of EREs. These other mechanisms for ER activation may correspond to other ways of mediating or enhancing the transcription via ERs in situations of low hormone levels .
The tissue distribution of the two receptors both overlaps and differs. ER␣ mRNA is predominantly expressed in the uterus, mammary gland, testis, pituitary, liver, kidney, heart, and skeletal muscles, whereas ER␤ mRNA is expressed in the ovary and prostate. The epididymis, thyroid, adrenals, gonad, and various regions of the brain show relatively equal levels of ER␣ and ER␤ mRNA. Within the tissues that coexpress both receptors, the cellular distribution between the estrogen receptor subtypes differs.
Generation of ERKO Mice

Utility of ERKO Models
In studying knockout mice that use homologous recombination in embryonic stem cells, scientists have been able to analyze the effects of the absence of a certain gene product on the viability, development, and physiology of the animal. This experimental approach has been used to generate three different knockout models that lack either ER␣ (␣ERKO) (Lubahn et al. 1993) or ER␤ (␤ERKO) (Krege et al. 1998) individually, or that lack both ER␣ and ER␤ genes (␣␤ERKO) (Couse et al. 2000; Dupont et al. 2000; Swope and Korach 2003) . In Table 1 , many of the reported phenotypes observed in mice with a disrupted estrogen receptor are summarized. The ERKO models provide a unique and valuable tool to assess the physiological consequences of the complete lack of ER activity and the role(s) each receptor may play in various tissues.
Expected Mendelian distribution of ER genotypes is seen in all breeding colonies with no bias in sex ratio. Moreover, in all three knockout models, the mice develop normally and have a life span comparable to their wild-type littermates. However, adult mice of each ERKO model exhibit several abnormal phenotypes unique to that model.
Fertility and Behavior
Both sexes of ␣ERKO mice are infertile (Couse and Korach 1999a,b; Lubahn et al. 1993) . No vaginal plugs or pregnan- cies were found in matings with ␣ERKO female mice. ␤ERKO males show normal fertility when compared with wild-type males, whereas ␤ERKO females exhibit reduced fertility (Krege et al. 1998) . In continuous matings, ␤ERKO females had fewer litters than the wild-type females, and the number of pups per litter was significantly lower. ␣␤ERKO males and females are infertile (Couse and Korach 1999a,b; Dupont et al. 2000) . Steroids like estrogens and progesterone are known to be involved in reproductive behavior. The availability of ␣ERKO, ␤ERKO, and ␣␤ERKO animals provide unique models to study the precise roles of ER␣ and ER␤ in reproductive behavior. Although ␤ERKO female mice have fewer litters and a reduced number of pups per litter compared to wild-type mice, they do not demonstrate any difference in behavior compared with wild-type animals (Ogawa et al. 1999) . In contrast, sexual behavior of ␣ERKO animals is altered. ␣ERKO females did not show the lordosis response and were also deficient in sexual behavioral interactions preceding the lordosis response (Ogawa et al. 1998; Rissman et al. 1997 ). In addition, ␣ERKO females were often attacked by the male, which may be partially due to the elevated levels of testosterone in ␣ERKO females. The lack of ER␣ and ER␤ in the hypothalamus during development has little effect on male sexual behavior in terms of mounting and sexual attraction toward wild-type females (Couse et al. 2001; Ogawa et al. 1997; Wersinger et al. 1997) . ␣ERKO males have slightly reduced levels of intromissions, rarely ejaculate, and have greatly reduced aggressive behavior.
␣ERKO males are completely insensitive to the activating effects of exogenous estradiol or androgen treatment (Couse et al. 2001; Ogawa et al. 1997 Ogawa et al. , 1998 . ␤ERKO males show no abnormalities in sexual behavior. In contrast, ␣␤ERKO males exhibit a complete disruption of sexual behavior, from both consummatory and motivational aspects. This characteristic suggests that ER␣ might be predominantly involved in the ability of the males to behave normally, whereas ER␤-dependent actions are important in the regulation of sexual behavior.
Animal Husbandry and Breeding
No special animal husbandry is necessary to maintain breeding colonies of either of the ERKO mouse lines, and all animals are genotyped by polymerase chain reaction on DNA extracted from tail biopsy. Due to the infertility of both the male and female ␣ERKO, ␣ERKO mice are obtained by breeding heterozygous males with heterozygous females. ␤ERKO mice are obtained by breeding ␤ERKO males with heterozygous females because some of the ␤ERKO females are subfertile. To generate mice homozygous for ER␣ and ER␤ (␣␤ERKO) mice heterozygous for both ER␣ and ER␤ are crossed.
Phenotypes of the Female Reproductive Tract
Uterus ER␣ is the predominant ER in the uterus. Adult ␣ERKO, ␤ERKO, and ␣␤ERKO females possess all three definitive uterine compartments: the myometrium, the endometrial stroma, and the epithelium. The ␤ERKO uterus appears normal and responds properly to hormones (Dupont et al. 2000; Krege et al. 1998) . However, in the ␣ERKO and ␣␤ERKO female mice, each compartment is hypoplastic, which results in uterine weights that are approximately one half the expected size relative to wild-type littermates (Figure 1) . Although the ␣ERKO females are fertile and can support pregnancy, the ␣ERKO and ␣␤ERKO females are infertile. Uteri from both ␣ERKO and ␣␤ERKO females have lost estrogen responsiveness and exhibit no increase in uterine wet weight after the administration of estradiol. Moreover, no increased expression of the estrogenresponsive genes progesterone receptor (PR 1 ), lactoferrin, and glucose-phosphatase gene could be demonstrated in estrogen-treated ␣ERKO uteri (Couse et al. 1995) . Nevertheless, PR protein is present in the ␣ERKO uterus, albeit at reduced levels, and PR-mediated actions have appeared to be preserved in ␣ERKO uteri (Curtis et al. 1999) . In wildtype mice, estrogen treatment induces PR mRNA and protein in the stroma, and down-regulates PR expression in the uterine epithelium . In contrast, the ␣ERKO females reveal up-regulation, but not downregulation, of PR in the uterine stroma, suggesting that the role of ER␣ in the regulation of PR in the uterus is tissue compartment specific.
Ovary
Both ER␣ and ER␤ are present in the ovary, but the distribution pattern differs among the different ovarian cell types (Kuiper et al. 1996; Sar and Welsch 1999; Schomberg et al. 1999) . ER␣ mRNA and protein, which are expressed minimally in the ovary, are located predominantly in the thecal layer. ER␤ mRNA and protein are highly expressed in the granulosa cells of the developing follicles. The lack of ERs appears to have no gross effect on ovarian differentiation. ␣ERKO, ␤ERKO, and ␣␤ERKO females all possess normal ovarian morphology at birth and during prenatal development (Couse and Korach 1999a; Krege et al. 1998; Schomberg et al. 1999) . In contrast, ovaries of adult knockout mice show distinct phenotypes unique to the loss of ER␣, ER␤, or both (Figure 1) .
Adult ␣ERKO ovaries contain hemorrhagic, cystic follicles with no signs of ovulation (Lubahn et al. 1993 ). Follicles of ␣ERKO females progress through the primordial, primary, and antral stages but do not reach the preovulatory stage.
␣ERKO ovaries produce and secrete increased amounts of estradiol and testosterone compared with wild-type animals (Couse et al. 1995 . Moreover, the adult ␣ERKO ovary shows increased levels of follicle-stimulating hormone (FSH 1 ), FSH receptor, and luteinizing hormone (LH 1 ) receptor mRNA compared with wild-type . Superovulation treatment of immature females before development of the cystic ovarian phenotype showed that ␣ERKO females can ovulate, although the number of oocytes derived from these knockout females was significantly less than immature wild-type females (Couse and Korach 1999a,b) . The dramatic phenotype in the ␣ERKO ovary appears to be secondary to the loss of ER␣ function in the hypothalamus . Disruption of the ER␣ gene results in very elevated LH serum levels due to a failure of the negative feedback action of estradiol on the hypothalamic-pituitary axis. The high levels of LH appear to be a major cause of the observed ␣ERKO ovarian phenotype. Treatment with the gonadotropin releasing hormone antagonist antide suppresses the high serum LH levels and prevents the polycystic ovarian phenotype.
Ovaries from ␤ERKO females show a different ovarian phenotype (Dupont et al. 2000; Krege et al. 1998 ). The ␤ERKO ovary shows a normal gross morphology, containing all of the stages of folliculogenesis including corpora lutea. Upon superovulation with exogenerous gonadotropins, however, ␤ERKO ovaries have been observed to release a reduced number of oocytes compared with wild-type ovaries (Krege et al. 1998) . Histological analysis of treated ovaries has revealed reduced numbers of corpora lutea and increased numbers of preovulatory follicles that had not released their oocyte. These data suggest that ER␤ may play a role within the ovary itself, possibly facilitating the ability of the ovary to respond to gonadotropins.
Adult ␣␤ERKO females exhibit an ovarian phenotype that is different from that observed in the individual knockout models Dupont et al. 2000) . Adult ␣␤ERKO female ovaries contain follicles, some of which have a large antrum but are devoid of corpora lutea. Surprisingly, these ovaries also contain tubule-like structures that resemble the seminiferous tubles of the testis. Additionally, the adult ␣␤ERKO ovary expresses mRNA of a specific Sertoli cell marker, Sox-9 ). These tubules were not present in prepubertal mice even though they comprised a large portion of the adult ovary and lacked the granulosa cell layer typical of a maturing follicle. This observation leads to the hypothesis that these structures are redifferentiated follicles, rather then developmentally formed testicular cord-like structures ). The observed loss of the oocyte in these follicles might trigger the cell reversal. Although other species have been described as having a morphological sex reversal of the ovary, the ␣␤ERKO is unique in that it is the first example of adult sex reversal ). These results indicate that in mice, female somatic cells retain the capacity to redifferentiate to Sertoli-like cells throughout life. Thus, both ERs are required for ovarian function and oocyte survival in adults.
Mammary Gland
Mammary gland development is based on multihormonal control (Bocchinfuso et al. 2000) , and development occurs in two major phases: ductal elongation during puberty, and lobuloalveolar development during pregnancy (Bocchinfuso et al. 2000; Korach et al. 2003) . A rudimentary ductal system is present at birth near the nipple area. During puberty, the ductal system expands through proliferation at the terminal end buds of each branch. At pregnancy and with lactation, the entire system undergoes further branching in-volving the formation of lobuloalveolar structures . Estradiol has been shown to stimulate the formation of terminal end buds directly and to stimulate cellular proliferation of the mammary ductal epithelium (Couse and Korach 1999a; Daniel et al. 1987) .
ER␣ is highly expressed in the adult mouse mammary gland, whereas ER␤ is only slightly detectable (Couse and Korach 1999b; Korach et al. 2003) . The ␣ERKO mammary gland exhibits normal prenatal and prepubertal development, but remains rudimentary after puberty, lacking the epithelial branching and lobuloalveolar development evident in wild-type glands (Bocchinfuso and Korach 1997; Korach et al. 2003) (Figure 1) . Unlike the underdevelopment of the ␣ERKO mammary gland, ␤ERKO females possess normal ductal structure, and the entire fat pad is filled, as with wild-type females (Krege et al. 1998) (Figure 1 ). After pregnancy, ␤ERKO mammary glands differentiate normally and reveal the lobuloalveolar structures necessary for lactation. The mammary gland of the adult ␣␤ERKO female resembles that of the ␣ERKO female (Figure 1) .
Both estrogen and progesterone are essential for ductal branching and lobuloalveolar development in the mammary gland. Because increased PR expression in the mammary glands depends on estrogen, the ␣ERKO mammary gland phenotype might be at least partially due to the lack of PR induction. In ␣ERKO mammary glands, basal PR mRNA expression is significantly reduced, and estrogen-stimulated increase in PR gene expression is lost (Bocchinfuso and Korach 1997) . In addition to progesterone, prolactin (PRL 1 ) is also necessary for full development of the mammary gland (Brisken et al. 1999) . PRL mRNA has been observed to be significantly reduced in the ␣ERKO pituitary, and PRL serum levels were lower in the ␣ERKO (Scully et al. 1997) . Therefore, the phenotype seen in the ␣ERKO female mammary gland is likely to be due to a direct action of estrogens on the gland itself as well as indirect mechanisms involving the hypothalamic-pituitary axis. Data resulting from comparisons of the mamary glands of ␣ERKO and ␤ERKO female mice indicate that ER␣ is the main receptor necessary for mediating estrogen action in the mammary gland.
Phenotypes of the Male Reproductive Tract
Spermatogenesis
Male fertility and reproduction has been thought to be regulated by androgens; a possible role of estrogens in male reproduction remained controversial until the generation of the ␣ERKO mouse model. There are no indications of defects in the development of the reproductive tract in ␣ERKO, ␤ERKO, or ␣␤ERKO male mice. Adult ␤ERKO male mice are fertile and have shown no apparent or obvious morphological phenotypes (Krege et al. 1998) . However, adult ␣ERKO males are completely infertile when tested in timed-mating studies with wild-type females (Couse et al. 2001; Eddy et al. 1996) . Further analysis of ␣ERKO males has revealed abnormal spermatogenesis, reflected by lower sperm counts that continue to decline with age (Couse and Korach 1999a) . Epididymal sperm collected from ␣ERKO males have shown an increase in the incidence of sperm head separating from the flagellae and decreased sperm motility (Couse et al. 2001 , Eddy et al. 1996 . Testes of the ␣ERKO male are somewhat smaller than those of wild-type males but contain the usual complement of seminferious tubules. Histological analysis has indicated atrophy and dilation of the tubular lumen (Hewitt and Korach 2002) (Figure 2) . Impaired spermatogenesis is not caused by defects in the germ cells. Rather, it is caused indirectly through disruption in the somatic cells in the ␣ERKO male reproductive tract. This characteristic has been shown by germ cell transplantation from donor ␣ERKO male to the testes of wild-type recipients (Mahato et al. 2000) . Thus, the disruption of ER␣ has resulted in serious impairments in both spermatogenesis and sperm function (Couse et al. 2001) (Figure 2 ). There were no abnormalities observed in the testes of ␤ERKO male mice (Dupont et al. 2000; Krege et al. 1998) (Figure  2 ). ␣␤ERKO males show an overall testicular phenotype similar to the ␣ERKO male (Couse and Korach 1999a,b; Dupont et al. 2000) .
Accessory Sex Organs
Accessory sex organs such as the prostate, bulbourethral glands, coagulating gland, and seminal vesicle all are androgen dependent and serve to secrete components necessary for seminal plasma (Couse et al. 2001 ). In the rat, ER has been detected in various stages of development in each of the accessory organs mentioned (Cooke et al. 1991; Couse et al. 2001) . Furthermore, ER␣ and ER␤ are expressed in the prostate of various species (Couse et al. 1997 (Couse et al. , 2001 Hess et al. 1997; Lau et al. 1998) . Although no apparent abnormality in the development of these accessory organ glands has been observed in the various ER knockout models, one striking observation in the ␣ERKO male is a significant increase in the weight of the seminal vesicle/ coagulating gland. This increase is more apparent with age and is most likely related to the slight increase in serum testosterone in the males (Couse et al. 2001 ).
Phenotypes of Nonreproductive Tissues
Estrogens and androgens are important for bone metabolism and homeostasis. Sex steroids are involved in bone modeling during adolescence and in the remodeling of bone in adulthood. Estradiol has been shown to be crucial for the maintenance of bone mass. Bone phenotypes observed in the ERKO mice show that femurs in ␣ERKO and ␣␤ERKO mice are shorter than in wild-type mice, but not in ␤ERKO Volume 45, Number 4mice (Hewitt and Korach 2002; Vidal et al. 1999 Vidal et al. , 2000 . It has been postulated that this characteristic is due to lower serum insulin-like growth factor-1 levels in these mice. Female ␣ERKOs have smaller bone diameters and males have lower bone density (Couse and Korach 1999b) . ␤ERKO females have been reported to have an increase in bone mineral density content, and no changes have been observed in the ␤ERKO males (Hewitt and Korach 2002; Windahl et al. 1999 Windahl et al. , 2001 ). These observations suggest that ER␤ may have a negative effect on bone density in the female mouse (Hewitt and Korach 2002) .
The protective factor of estrogen against cardiovascular disease in females may be due to their natural increased exposure to estrogens (Couse and Korach 1999a ). An aortic injury model using the ERKO mouse models has analyzed the protective effects of estrogen on cardiovascular health. Those studies have indicated that ER␣, but not ER␤, is needed to provide the protective estrogenic effects on vascular injury. Effects on reducing atherosclerosis and cholesterol levels were studied by crossing apolipoprotein E (ApoE 1 ) mice with ␣ERKO or ␤ERKO. The crosses indicated that estrogen treatment reduces atherosclerosis in wild-type mice. These effects were absent in the ␣ERKO/ ApoE mice but still present in ␤ERKO/ApoE mice, indicating a receptor-mediated role for ER␣ in this process (Hodgin et al. 2001 ).
Summary
Targeted disruption of the different ER genes has resulted in animal models that are very useful in evaluating the distinct and cooperative roles of ER␣ and ER␤ in reproductive and nonreproductive tissues. As described above, wellestablished phenotypes have been observed in various ERKO mouse lines. Future investigations using new mouse lines with modified estrogen receptors will allow investigators to continue evaluating the role of estrogen in normal physiology.
